3 unknown, 2 completed, 2 recruiting. 7 Phase 2, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Unknown 3, Completed 2, Recruiting 2 |
| Phase 3 | 2 | Recruiting 1, Unknown 1 |
Follow Child: new trials by email Literature Review of Child trials Research Report on Child
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Brentuximab Vedotin for Newly Diagnosed cHL in Chinese CAYA Based on PET/CT Assessment Brentuximab Vedotin for Injection, response-adapted radiation, Doxorubicin - Classical Hodgkin Lymphoma, Child | Phase 2 / Phase 3 | Recruiting | Children's Cancer Group, China | 96 | 2024-09-25 | 2026-03-19 |
| Clemastine Fumarate in the Treatment of Neurodevelopmental Delays in Williams Syndrome Clemastine Fumarate Tablets, corn starch tablets - Williams Syndrome, Child | Phase 2 | Completed | Qilu Hospital of Shandong University | 28 | 2024-03-20 | 2026-03-19 |
| Bovine Colostrum for Prophylaxis Against Recurrent Urinary Tract Infection in Children Bovine colostrum, Placebo - Urinary Tract Infections, Recurrent | Phase 2 | Completed | Ain Shams University | 60 | 2023-06-01 | 2026-01-02 |
| A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer Ramucirumab, Cyclophosphamide, Vinorelbine - Neoplasms, Child | Phase 2 | Recruiting | Eli Lilly and Company | 105 | 2020-01-22 | 2026-08-07 |
| Treatment of NF1-related Plexiform Neurofibroma With Trametinib Trametinib - Neurofibromatosis 1, Child | Phase 2 | Unknown | Region Skane | 15 | 2019-06-10 | 2024-04-11 |
| Pharmacokinetic Study of Lipo-PGE1 for Prevention of VOD After HSCT lipoprostaglandin E1 - Veno-occlusive Disease, Child | Phase 2 / Phase 3 | Unknown | Seoul National University Hospital | 30 | 2015-01-01 | 2021-03-30 |
| Treatment of Newly Diagnosed High Risk Acute Lymphoblastic Leukemia in Children high dose methotrexate, Intrathecal triple chemotherapy - Acute Lymphoblastic Leukemia, Child | Phase 2 | Unknown | The Korean Society of Pediatric Hematology Oncology | 110 | 2015-01-01 | 2015-01-16 |
Communicable Diseases (1) · Infections (1) · Neoplasms (1) · Neurofibroma, Plexiform (1) · Neurofibromatosis 1 (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1) · Recurrence (1) · Urinary Tract Infections (1) · Urologic Diseases (1) · Williams Syndrome (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2) · Genetic Diseases, Inborn (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Nervous System Diseases (2) · Aortic Stenosis, Supravalvular (1) · Aortic Valve Disease (1) · Aortic Valve Stenosis (1) · Cardiovascular Diseases (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Disease Attributes (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Heart Diseases (1)
Cyclophosphamide (2) · Brentuximab Vedotin (1) · Clemastine (1) · Dacarbazine (1) · Docetaxel (1) · Doxorubicin (1) · Etoposide (1) · Gemcitabine (1) · Injections (1) · Irinotecan (1) · Methotrexate (1) · Prednisone (1) · Ramucirumab (1) · Starch (1) · Temozolomide (1)
Ain Shams University (1) · Children's Cancer Group, China (1) · Eli Lilly and Company (1) · Qilu Hospital of Shandong University (1) · Region Skane (1) · Seoul National University Hospital (1) · The Korean Society of Pediatric Hematology Oncology (1)
China (2) · South Korea (2) · Australia (1) · Belgium (1) · Egypt (1) · France (1) · Germany (1) · Italy (1) · Japan (1) · Netherlands (1) · Spain (1) · Sweden (1) · United Kingdom (1) · United States (1)
2018 (1)